Physician profile
Shouwen Wang
NPI 1700889326
$6,542.66
in general payments reported to CMS, 2019-2025
12 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,600 · 2020: $468 · 2021: $915 · 2023: $28.46 · 2024: $116 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468 · Education: $90.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.18 |
| Education | $90.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $5,948.73 | 2019-2024 | Product In Development |
| Bard Peripheral Vascular, INC. | $179.48 | 2020-2023 | Fluency Endovascular Stent Graft |
| Sonavex, INC. | $93.00 | 2025 | Echomark, Echosure |
| Mallinckrodt Hospital Products INC. | $90.90 | 2025 | Acthar |
| Janssen Biotech, INC. | $80.74 | 2025 | Rybrevant |
| Bayer Healthcare Pharmaceuticals INC. | $43.56 | 2025 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $29.42 | 2025 | |
| Renalytix Ai, INC. | $22.45 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Otsuka America Pharmaceutical, INC. | $20.22 | 2025 | Jynarque |
| Novartis Pharmaceuticals Corporation | $20.16 | 2025 | |
| Ethicon US, LLC | $14.00 | 2025 | Minivac |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shouwen Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.